Houssam Ibrahim

Title: Houssam Ibrahim: Innovator in Pharmaceutical Chemistry

Introduction

Houssam Ibrahim is a notable inventor based in Veyrier, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of oxaliplatin preparations. With a total of 5 patents to his name, Ibrahim continues to push the boundaries of innovation in his field.

Latest Patents

Ibrahim's latest patents include groundbreaking work on an oxaliplatin active substance with a very low content of oxalic acid. This invention relates to a pharmaceutical composition where the weight content of oxalic acid does not exceed 0.08%. Additionally, he has developed a pharmaceutically stable oxaliplatinum preparation for parenteral administration. This preparation is characterized by a precipitate-free, colorless, and clear solution, which remains stable for a pharmaceutical acceptable duration. The oxaliplatinum is contained in a solution at a concentration of at least 7 mg/ml, utilizing a solvent that includes hydroxylated derivatives such as 1,2-propanediol, glycerol, maltitol, saccharose, and inositol.

Career Highlights

Houssam Ibrahim is currently associated with Debiopharm S.A., a company known for its commitment to developing innovative cancer therapies. His work at Debiopharm has allowed him to focus on creating effective pharmaceutical solutions that address critical medical needs.

Collaborations

Ibrahim collaborates with esteemed colleagues such as Henri Pourrat and Rolland-Yves Mauvernay. Their combined expertise contributes to the advancement of pharmaceutical innovations and enhances the research environment at Debiopharm.

Conclusion

Houssam Ibrahim stands out as a prominent inventor in the pharmaceutical industry, with a focus on improving oxaliplatin formulations. His contributions are vital to the ongoing development of effective cancer treatments.